CNS Drugs

Total Intravenous Anaesthesia: Is it Worth the Cost?
pp. 609-619(11)
Author: Smith I.

Pain in Terminally Ill Patients: Guidelines for Pharmacological Management
pp. 621-631(11)
Authors: Thomas J.R.; von Gunten C.F.

Antiepileptic Drug-Induced Pharmacodynamic Aggravation of Seizures: Does Valproate Have a Lower Potential?
pp. 633-640(8)
Authors: Hirsch E.; Genton P.

The Glutamatergic System and Alzheimer’s Disease: Therapeutic Implications
pp. 641-652(12)
Authors: Butterfield D.A.; Pocernich C.B.

Speed of Onset and Efficacy of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine: A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study versus Zolmitriptan Tablet
pp. 653-667(15)
Authors: Charlesworth B.R.; Dowson A.J.; Purdy A.; Becker W.J.; Boes-Hansen S.; Färkkilä M.

SLI-381 (Adderall XR^®)
pp. 669-675(7)
Authors: McKeage K.; Scott L.J.

SLI-381 (Adderall XR®): A Viewpoint by Charlotte Johnston
pp. 676-677(2)
Author: Johnston C.

SLI-381 (Adderall XR®): A Viewpoint by Paul J. Ambrosini
pp. 676-677(2)
Author: Ambrosini P.J.

Opinion and Evidence in Neurology and Psychiatry
pp. 679-687(9)
Author: Limited A.I.